'We look like what the future of all biopharma companies will look like', says Recursion CEO Gibson

Поділитися
Вставка
  • Опубліковано 28 лис 2024

КОМЕНТАРІ • 7

  • @scottiebumich
    @scottiebumich Рік тому +3

    Scam. Horrible pipeline and the later assets are in small indications with no real demand.

  • @Bham67
    @Bham67 7 місяців тому +1

    Talk is cheap. CEO can run his mouth and tell stories and prognosticate all day, but in the end, the proof is in the pudding. Recursion has no significant or consistent success stories. They are unprofitable and their losses increase each quarter. Dude needs to stop gloating over things he hasn't even done. Less talk, more action.

  • @matt37221
    @matt37221 5 місяців тому

    incoming bubble